This article was originally published in The Tan Sheet
Pharma vets acquire Nutrition 21 assets; FDA approves Perrigo’s generic Mucinex; Pfizer closes Ferrosan consumer health deal; DEA allows PSE log flexibility; and more OTC drug and nutritional product market news In Brief
You may also be interested in...
Nutrition 21 Files For Bankruptcy, Hamstrung By Finished Product Detour
Ingredient developer Nutrition 21 filed for Chapter 11 bankruptcy protection and is soliciting bidders for its assets following an unsuccessful transition into the finished nutritional product space.
Watson prevails in Mucinex patent ruling
Pfizer Buys Ferrosan Consumer Unit, Expands In Russia And Northern Europe
Pfizer expands its distribution in the Nordic states and Russia markets with the acquisition of the Danish firm Ferrosan's consumer health care unit.